Key result
Left atrial appendage device closure is a viable non-pharmacological alternative to oral anticoagulation for the prevention of thromboembolism in patients with atrial fibrillation.
Why the study?
Does left atrial appendage device closure prevent thromboembolism and improve survival compared to oral anticoagulation in patients with non-valvular atrial fibrillation?
Does left atrial appendage device closure prevent thromboembolism and improve survival compared to oral anticoagulation in patients with non-valvular atrial fibrillation?
Left atrial appendage closure is a viable non-pharmacological alternative to oral anticoagulation for thromboembolism prevention in patients with non-valvular atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Supports LAA closure consideration in select AF patients; leaves open need for RCTs before practice change.
A 2014 study conducted a review in Atrial fibrillation. Left atrial appendage device closure vs. Oral anticoagulation / Vitamin K antagonists was evaluated. Left atrial appendage device closure is a viable non-pharmacological alternative to oral anticoagulation for the prevention of thromboembolism in patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: